Alector, Inc. (ALEC)
Data as of Nov 3, 12:51 PM ETPrices may be delayedHow our data works
Res / Sup are automatic swing levels for educational reference only — not signals or advice.
Prices may be delayed. For informational purposes only — not investment advice.
ALEC key stats
ALEC GlowScore: Active
A 0–100 read on today's activity from volume, momentum and intraday range. Not a buy or sell signal.
About Alector, Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
What's moving ALEC today
Updated November 3, 2026As of November 3, 2026, Alector, Inc. (ALEC) stock fell to $2.10, down 2.33% (-$0.05) versus the previous close. On the day, shares have traded between $2.10 and $2.25. That puts ALEC around the middle of its 52-week range of $1.09 to $2.76. Alector, Inc. operates in the biological products, (no diagnostic substances) space and carries a market capitalization of roughly $246.76 million, with about 793.5K shares changing hands.
Latest ALEC news
- What Alector Shareholders Got RightYahoo Finance· Nov 3, 12:10 AM ET
- Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to DeclineYahoo Finance· Oct 30, 9:00 AM ETMRNA
- Will Alector (ALEC) Report Negative Q3 Earnings? What You Should KnowYahoo Finance· Oct 29, 9:00 AM ET
- Alector stock surges 13% on premium-priced equity offeringYahoo Finance· Oct 16, 9:26 AM ET
- Alector Announces Pricing of Underwritten OfferingYahoo Finance· Oct 16, 7:30 AM ET
- Alector (ALEC) Stock Fair Value Rises After Genentech Deal Draws Split Analyst ViewsYahoo Finance· Oct 15, 8:21 PM ET
- Alector Maps Brain-Delivery Pipeline for Alzheimer’s, Parkinson’s Therapiesmarketbeat.com· Oct 13, 3:02 PM ET
- Stocktwits Biotech Dealmaker — Viatris And GE Healthcare Buy What They Can Sell; Biohaven And Alector Sell Rightsstocktwits.com· Oct 9, 9:12 PM ET
Source: Yahoo Finance RSS · Updated November 3, 2026
Want ALEC headlines, alerts and AI research in one place? Create a free account →
ALEC buzz on Stocktwits
1,916 watchers$ALEC Break the Bulls out and let this fly!!!
@Cornlikker· Nov 3, 11:51 AM ET· Bullish
$ALEC extremely bullish
@CC123italy· Nov 3, 10:03 AM ET· Bullish
$ALEC can see this hitting 4
@CC123italy· Nov 1, 7:11 PM ET· Bullish
$ALEC 160k @ 2.25 at 4.00pm on time n sale
@Yoyo877· Oct 28, 4:10 PM ET· Bullish
$ALEC why is this up when theres an offering?
@1234counting· Oct 28, 3:53 PM ET
Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →
ALEC Congress & insider trades
Congress amounts are the disclosed ranges; filings can lag the trade date by up to 45 days.
AI research on ALEC
Get an instant AI breakdown of the bull & bear case, key risks, and what analysts are watching.
Not financial advice. This page is for educational purposes only. Data comes from third-party sources, may be delayed or incomplete, and should not be the basis of any investment decision.